Infect Chemother.  2017 Mar;49(1):38-43. 10.3947/ic.2017.49.1.38.

Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact

Affiliations
  • 1Department of Pediatrics, Kyung Hee University Hospital, Seoul, Korea.
  • 2Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea. myhan44@naver.com
  • 3Department of Diagnostic Radiology, Kyung Hee University School of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Mycoplasma is a common cause of respiratory infections and may require differential diagnosis from Kawasaki disease (KD). In this study, we investigated the frequency and clinical manifestations of mycoplasma infection in patients with KD.
MATERIALS AND METHODS
Medical records of 375 in-patients admitted for treatment during the acute stage of KD, were collected, and reviewed retrospectively. Of these patients, 152 (40.5%) were also tested for recent mycoplasma infection. Patients with positive results (anti-mycoplasma IgM Ab >1:640 or cold agglutinin >1:64) were designated as the case group (n = 37, 24.3%) whereas those with negative results were designated as the control group (n = 115, 75.7%). Clinical findings of the two groups were compared.
RESULTS
Patients in the case group were older than those in the control group (mean age, 48.2 ± 32.1 months, vs. 31.7 ± 21.7 months; P = 0.001). There were significant differences between the case and control groups in the changes in the extremities (78.3% vs. 57.4%, respectively; P = 0.031), and in fever duration (6.5 ± 2.5 days vs. 5.4 ± 1.5 days; P = 0.047). Of the 37 patients with positive mycoplasma testing, 7 (18.9%) had persistent fever even after the symptoms and signs of systemic inflammation (acute phase of KD) had been resolved. These patients were positive for mycoplasma infection during further evaluation of persistent fever, and all of them responded to macrolide antibiotics.
CONCLUSIONS
We found that mycoplasma infection is somewhat related to KD. When fever persists after resolution of the acute stage of KD, mycoplasma infection may be considered as a possible cause of fever in preschool-aged children.

Keyword

Mycoplasma; Mycoplasma infections; Kawasaki disease

MeSH Terms

Anti-Bacterial Agents
Child
Diagnosis, Differential
Extremities
Fever*
Humans
Immunoglobulin M
Immunoglobulins*
Inflammation
Medical Records
Mucocutaneous Lymph Node Syndrome*
Mycoplasma Infections*
Mycoplasma*
Respiratory Tract Infections
Retrospective Studies
Anti-Bacterial Agents
Immunoglobulin M
Immunoglobulins

Figure

  • Figure 1 Distribution of Kawasaki disease patients who underwent testing for mycoplasma and those who tested positive for mycoplasma (January 1, 2000 – December 31, 2013). Myco, Mycoplasma pneumonia; KD, Kawasaki disease.

  • Figure 2 Clinical course of case No. 4 (see Table 3) IVIG, intravenous immunoglobulin; HD, hospital day; BT, body temperature; CRP, c-reactive protein


Reference

1. Takahashi K, Oharaseki T, Yokouchi Y. Pathogenesis of Kawasaki disease. Clin Exp Immunol. 2011; 164:Suppl 1. S20–S22.
Article
2. Jordan-Villegas A, Chang ML, Ramilo O, Mejias A. Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr Infect Dis J. 2010; 29:770–772.
Article
3. Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, Cheng AL, Lee WL, Hu JJ, Yeh SJ, Chang CC, Chiang BL, Wu MH, Huang LM. Viral infections associated with Kawasaki disease. J Formos Med Assoc. 2014; 113:148–154.
Article
4. Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev. 2012; 10:CD009175.
5. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease. Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110:2747–2771.
Article
6. Chung EH. Serologic diagnosis of Mycoplasma pneumoniae infection. Korean J Pediatr Infect Dis. 2006; 13:21–30.
Article
7. Son MB, Newburger JW. Kawasaki Disease. In : Kliegman R, Stanton B, Geme J, Schor N, editors. Nelson Textbook of Pediatrics. 20th ed. Philadelphia: WB Saunders Co;2015. p. 1209.
8. Lee MN, Cha JH, Ahn HM, Yoo JH, Kim HS, Sohn S, Hong YM. Mycoplasma pneumonia infection in patients with Kawasaki disease. Korean J Pediatr. 2011; 54:123–127.
Article
9. Chung SW, Kim SH. Analysis of genotype distribution and detection rate of Mycoplasma pneumoniae according to respiratory disease type. Public Health Weekly Report. 2014; 7:177–181.
10. Greco F, Sorge A, Salvo V, Sorge G. Cutaneous vasculitis associated with Mycoplasma pneumoniae infection: case report and literature review. Clin Pediatr (Phila). 2007; 46:451–453.
Article
11. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumonia infections. FEMS Microbiol Rev. 2008; 32:956–973.
Article
12. Choi MH, Park CS, Kim DS, Kim KH. Prediction of intravenous immunoglobulin nonresponse Kawasaki disease in Korea. Korean J Pediatr Infect Dis. 2014; 21:29–36.
Article
13. Kim SK, Han JY, Rhim JW, Oh JH, Han JW, Lee KY, Kang JH, Lee JS. Limitation of prediction on intravenous immunoglobulin responsiveness in Kawasaki Disease. Korean J Pediatr Infect Dis. 2010; 17:169–176.
Article
14. Youn YS, Lee SC, Rhim JW, Shin MS, Kang JH, Lee KY. Early additional immune-modulators for Mycoplasma pneumoniase pneumonia in children: an observation study. Infect Chemother. 2014; 46:239–247.
Article
15. Csángó PA, Pedersen JE, Hess RD. Comparison of four Mycoplasma pneumonia IgM-, IgG- and IgA specific enzyme immunoassays in blood donors and patients. Clin Microbiol Infect. 2004; 10:1094–1098.
Article
16. Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpää R, Mertsola J, Ruuskanen O. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol. 1998; 36:3155–3159.
Article
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr